Research ArticleOriginal Research
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing
Yosuf W Subat, Todd J Meyer, Keith D Torgerud, Kaiser G Lim, Paul D Scanlon and Alexander S Niven
Respiratory Care May 2022, respcare.09703; DOI: https://doi.org/10.4187/respcare.09703
Yosuf W Subat
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Todd J Meyer
Respiratory Care, Mayo Clinic, Rochester, Minnesota.
Keith D Torgerud
Respiratory Care and Cardiopulmonary Diagnostics, Mayo Clinic, La Crosse, Wisconsin.
Kaiser G Lim
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Paul D Scanlon
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Alexander S Niven
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
In this issue
Respiratory Care
Vol. 69, Issue 4
1 Apr 2024
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing
Yosuf W Subat, Todd J Meyer, Keith D Torgerud, Kaiser G Lim, Paul D Scanlon, Alexander S Niven
Respiratory Care May 2022, respcare.09703; DOI: 10.4187/respcare.09703
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing
Yosuf W Subat, Todd J Meyer, Keith D Torgerud, Kaiser G Lim, Paul D Scanlon, Alexander S Niven
Respiratory Care May 2022, respcare.09703; DOI: 10.4187/respcare.09703